Local bacteria affect the efficacy of chemotherapeutic drugs

Cited by (313)

Items 101–200 of 313

1. Evolved bacterial resistance against fluoropyrimidines can lower chemotherapy impact in the Caenorhabditis elegans host
   Brittany Rosener, Serkan Sayin, Peter O. Oluoch, Aurian P. García-González, Hirotada Mori, Albertha J.M. Walhout, Amir Mitchell · 2020 · eLife
2. Fusobacterium nucleatum : a novel immune modulator in breast cancer?
   Alexa Little, Mark Tangney, Michael M. Tunney, Niamh E. Buckley · 2023 · Expert Reviews in Molecular Medicine
3. Designer bacteria as intratumoural enzyme biofactories
   Panos Lehouritis, G. E. Hogan, Mark Tangney · 2017 · Advanced Drug Delivery Reviews
4. The Gut Microbiota in Causation, Detection, and Treatment of Cancer
   Clodagh L. Murphy, Paul William O’Toole, Fergus Shanahan · 2019 · The American Journal of Gastroenterology
5. The role of intratumoral microbiome in the occurrence, proliferation, metastasis of colorectal cancer and its underlying therapeutic strategies
   Kaili Liao, Jiarong Wen, Ziqian Liu, Beining Zhang, Xue Zhang, Yuxin Fu, Wenyige Zhang, Huan Hu, Kun Ai, Wenqing Zhu et al. · 2025 · Ageing Research Reviews
6. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective
   Concetta Panebianco, Davide Ciardiello, Annacandida Villani, Brigida Anna Maiorano, Tiziana Pia Latiano, Evaristo Maiello, Francesco Perri, Valerio Pazienza · 2021 · Seminars in Cancer Biology
7. The intratumoural microbiota in cancer: new insights from inside
   Yaping An, Wanru Zhang, Tianyu Liu, Bangmao Wang, Hailong Cao · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
8. The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
   Martina Di Modica, Valeria Arlotta, Lucia Sfondrini, Elda Tagliabue, Tiziana Triulzi · 2022 · Frontiers in Oncology
9. Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells
   Serkan Sayin, Brittany Rosener, Carmen G Li, Bao Ho, Olga Ponomarova, Doyle V. Ward, Albertha J.M. Walhout, Amir Mitchell · 2023 · eLife
10. Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
    Kunika, Norbert Frey, Ashraf Yusuf Rangrez · 2023 · International Journal of Molecular Sciences
11. Role of the oral-gut microbiota axis in pancreatic cancer: a new perspective on tumor pathophysiology, diagnosis, and treatment
    Xuanchi Guo, Yuhan Shao · 2025 · Molecular Medicine
12. Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut
    Qin Yu, Christian Jobin, Ryan Michael Thomas · 2021 · Neoplasia
13. Self‐Targeted Co‐Delivery of an Antibiotic and a Cancer‐Chemotherapeutic from Synthetic Liposomes for the Treatment of Infected Tumors
    Da‐Yuan Wang, Yuanlong Cao, Guang Yang, Siyu Zhang, Henny C. van der Mei, Yijin Ren, Theo G. van Kooten, Derk Jan A. de Groot, Jacco Juri de Haan, Linqi Shi et al. · 2023 · Advanced Functional Materials
14. Mechanisms and Potential Clinical Implications of Oral Microbiome in Oral Squamous Cell Carcinoma
    Jingyi Wang, Bo Gao · 2023 · Current Oncology
15. Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy
    See-Khai Lim, Wen-Ching Lin, Sin‐Wei Huang, Yi‐Chung Pan, Che-Wei Hu, Chung‐Yuan Mou, Che‐Ming Jack Hu, Kurt Yun Mou · 2024 · EMBO Molecular Medicine
16. Antibacterial nanosystems for cancer therapy
    Jingdong Rao, Yuhe Yang, Ho‐Pan Bei, Chak Yin Tang, Xin Zhao · 2020 · Biomaterials Science
17. Biopsy bacterial signature can predict patient tissue malignancy
    G. E. Hogan, Julia Eckenberger, Neegam Narayanen, Sidney P. Walker, Marcus Joakim Claesson, Mark Anthony Corrigan, Deirdre M O'Hanlon, Mark Tangney · 2021 · Scientific Reports
18. Microbial and molecular differences according to the location of head and neck cancers
    Yun Kyeong Kim, Eun Jung Kwon, Yeuni Yu, Jayoung Kim, Soo-Yeon Woo, Hee-Sun Choi, Munju Kwon, Keehoon Jung, Hyung-Sik Kim, Hae Ryoun Park et al. · 2022 · Cancer Cell International
19. The role of gut microbiota in the development of colorectal cancer: a review
    Navami Prabhakar Koyande, Madhusree Gangopadhyay, Shashidhar Thatikonda, Aravind Kumar Rengan · 2022 · International Journal of Colorectal Disease
20. Understanding and harnessing triple-negative breast cancer-related microbiota in oncology
    Ciarán Devoy, Yensi Flores Bueso, Mark Tangney · 2022 · Frontiers in Oncology
21. Awareness of intratumoral bacteria and their potential application in cancer treatment
    Yin Liang, Qiyan Li, Yulin Liu, Yajie Guo, Qingjiao Li · 2023 · Discover Oncology
22. The Role of Microbiota in Pancreatic Cancer
    Valerio Papa, Tommaso Schepis, Gaetano Coppola, Michele Francesco Chiappetta, Livio Enrico Del Vecchio, Tommaso Rozera, Giuseppe Quero, Antonio Gasbarrini, Sergio Alfieri, Alfredo Papa · 2023 · Cancers
23. The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy
    Jae-Ho Kim, Heung Kyu Lee · 2021 · Molecules and Cells
24. Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment
    Anne T. Knisely, Yongwoo David Seo, Jennifer Ann Wargo, Manoj Chelvanambi · 2023 · Cancers
25. Bile Acids and Microbiota Interplay in Pancreatic Cancer
    Pratibha Malhotra, Ranjith Palanisamy, Jose Antonio Caparros-Martin, Marco Falasca · 2023 · Cancers
26. Different evasion strategies in multiple myeloma
    Chaofan Wang, Wanting Wang, Moran Wang, Jun Deng, Chunyan Sun, Yu Hu, Shanshan Luo · 2024 · Frontiers in Immunology
27. Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications—A Literature Review
    Mengjiao Wu, Chenjun Tian, Zhenwei Zou, Jin Min, Hongli Liu · 2024 · Cancers
28. Breast cancer: the first comparative evaluation of oncobiome composition between males and females
    Elena Niccolai, Simone Baldi, Giulia Nannini, Francesca Gensini, Laura Papi, Vania Vezzosi, Simonetta Bianchi, Lorenzo Orzalesi, Matteo Ramazzotti, Amedeo Amedei · 2023 · Biology of Sex Differences
29. Multi-omics analysis elucidates the relationship between intratumor microbiome and host immune heterogeneity in breast cancer
    Jia Li, Yu Zhang, Yifan Cai, Peizhuo Yao, Yiwei Jia, Xinyu Wei, Chong Du, Shuqun Zhang · 2024 · Microbiology Spectrum
30. Cancer and the Microbiome of the Human Body
    Lourdes Herrera‐Quintana, Héctor Vázquez‐Lorente, María López-Garzón, Adrián Cortés‐Martín, Julio Plaza‐Díaz · 2024 · Nutrients
31. How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?
    Inês Mendes, Nuno Vale · 2023 · International Journal of Molecular Sciences
32. New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
    Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino, Alessandro Allegra · 2020 · International Journal of Molecular Sciences
33. Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling
    Lixuan Wang, Weibo Jiang, Manshi Yang, Quezhu Danzeng, Shiyu Liu, Mengying Cui · 2025 · Cell Communication and Signaling
34. The microbiome in pediatric oncology
    Seth Joshua Rotz, Christopher E. Dandoy · 2020 · Cancer
35. Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study
    Yoshiko Kitazume, Hitoshi Kawazoe, Ryuji Uozumi, Tomoe Yoshizawa, Hirotoshi Iihara, Hironori Fujii, Masaya Takahashi, Takahiro Arai, Yasushi Murachi, Yumiko Sato et al. · 2022 · Scientific Reports
36. Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy
    Jinjing Zhang, Penghui Wang, Jiafeng Wang, Xiaojie Wei, Mengchuan Wang · 2024 · Pharmacological Research
37. Microbiome and cancer: from mechanistic implications in disease progression and treatment to development of novel antitumoral strategies
    Marian Constantin, Mariana Carmen Chifiriuc, Grigore Mihăescu, Nicolae Corcionivoschi, Liliana Burlibaşa, Coralia Bleoţu, Sorin Ioan Tudorache, Magda Mihaela Mitache, Roxana Filip, Simona-Gloria Munteanu et al. · 2024 · Frontiers in Immunology
38. Silver-Nanoparticle-Mediated Therapies in the Treatment of Pancreatic Cancer
    Rachel Foulkes, Mohsen Ali Asgari, Anthony D. M. Curtis, Clare Hoskins · 2019 · ACS Applied Nano Materials
39. Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
    Weici Laurence Liu, Zheshun Pi, Xiaokun Wang, Chenwei Shang, Chenghu Song, Ruixin Wang, Zhao He, Xu Zhang, Yuan Wan, Wenjun Mao · 2024 · Critical Reviews in Oncology/Hematology
40. The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy
    Mostafa A. Madkour, Rawan A. Altaf, Zeinab S. Sayed, Noha S. Yasen, Hanan A. Elbary, Reem A. Elsayed, Esraa N. Mohamed, Mohamed Toema, Al-Hassan Soliman Wadan, Mohamed H. Nafady et al. · 2024 · Advanced Gut & Microbiome Research
41. Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
    Michael Guenther, Michael Haas, Volker Heinemann, Stephan Krüger, Christoph Benedikt Westphalen, Michael von Bergwelt‐Baildon, Julia V. Mayerle, Jens Werner, Thomas Kirchner, Stefan Hubert Boeck et al. · 2020 · British Journal of Cancer
42. The Intratumor Bacterial and Fungal Microbiome Is Characterized by HPV, Smoking, and Alcohol Consumption in Head and Neck Squamous Cell Carcinoma
    Jaideep Chakladar, Daniel John, Shruti Magesh, Matthew Uzelac, Wei Tse Li, Kypros J. Dereschuk, Lauren Apostol, Kevin T. Brumund, Jessica-Wang Rodriguez, Weg M. Ongkeko · 2022 · International Journal of Molecular Sciences
43. Role of the intratumoral microbiome in tumor progression and therapeutics implications
    Yufan Meng, Zhiyao Fan, Bin Zhou, Hanxiang Zhan · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
44. Progress of tumor-resident intracellular bacteria for cancer therapy
    Peng Bao, Xian‐Zheng Zhang · 2024 · Advanced Drug Delivery Reviews
45. Enzymatic carbon–fluorine bond cleavage by human gut microbes
    Probst, Silke I., Felder, Florian D., Poltorak, Victoria, Mewalal, Ritesh, Blaby, Ian K., Robinson, Serina L. · 2025 · Proceedings of the National Academy of Sciences
46. Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
    Taymin du Toit‐Thompson, Lionel Yi Wen Leck, Josef Gillson, Nick Pavlakis, Anthony James Gill, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2025 · Advanced Drug Delivery Reviews
47. Bacterial infections in cancer: A bilateral relationship
    Abhirup Basu, Rohini Singh, Shalini Gupta · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
48. Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?
    Anne‐Gaëlle Goubet · 2023 · Frontiers in Oncology
49. Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions
    Siyuan Lu, Jie Hua, Jin Xu, Miaoyan Wei, Chen Liang, Qingcai Meng, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu et al. · 2021 · International Journal of Biological Sciences
50. Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
    Inês Mendes, Nuno Vale · 2024 · Biomedicines
51. Exploring the Impact of Chemotherapy on the Emergence of Antibiotic Resistance in the Gut Microbiota of Colorectal Cancer Patients
    Mutebi John Kenneth, Chin-Chia Wu, Chuan‐Yin Fang, Tsui-Kang Hsu, I‐Ching Lin, Shih-Wei Huang, Yi‐Chou Chiu, Bing‐Mu Hsu · 2025 · Antibiotics
52. Engineering Bacteria as Living Therapeutics in Cancer Therapy
    Jiangfeng Chen, Jiaqi Chen, Yixuan Chen, Wenxuan Yuan, Jiao Zhang, Guoqing Wang, Zhuojun Dai · 2025 · Advanced Science
53. Human Breast Tissue Microbiota Reveals Unique Microbial Signatures that Correlate with Prognostic Features in Adult Ethiopian Women with Breast Cancer
    Zelalem Desalegn, Alana Smith, Meron Yohannes, Xueyuan Cao, Endale Anberber, Yonas Bekuretsion, Mathewos Assefa, Marcus Bauer, Martina Vetter, Eva Johanna Kantelhardt et al. · 2023 · Cancers
54. Antibacterial metal-phenolic nanosheets as smart carriers for the controlled release of epirubicin hydrochloride
    Wei Ha, Jun‐Li Yang, Yan‐Ping Shi · 2022 · Nanoscale
55. Pancreatic Cancer Resistance to Treatment: The Role of Microbiota
    Enrico Celestino Nista, Angelo DEL GAUDIO, Livio Enrico Del Vecchio, Teresa Mezza, Giulia Pignataro, Andrea Piccioni, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli · 2023 · Biomedicines
56. The human microbiome: redefining cancer pathogenesis and therapy
    Yogita K. Adlakha, Ravindresh Chhabra · 2025 · Cancer Cell International
57. Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation
    Yao Yao, Xiaoyu Tracy Cai, Weidong Fei, Fujia Ren, Fengmei Wang, Xiaofei Luan, Fengying Chen, Caihong Zheng · 2020 · Frontiers in Pharmacology
58. Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines
    Abdallah Ladaycia, Brigitta Loretz, Catherine Passirani, Claus‐Michael Lehr, Élise Lepeltier · 2020 · Advanced Drug Delivery Reviews
59. Bacterial Antigens Reduced the Inhibition Effect of Capsaicin on Cal 27 Oral Cancer Cell Proliferation
    Rajdeep Chakraborty, Karen Vickery, Charbel Darido, Shoba Ranganathan, Honghua Hu · 2021 · International Journal of Molecular Sciences
60. Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy
    Peng Cheng, Peiliang Shen, Yunlong Shan, Yang Yu, Rui Deng, Wenxing Chen, Yin Lu, Zhonghong Wei · 2021 · Frontiers in Cell and Developmental Biology
61. Antimicrobial Prophylaxis and Modifications of the Gut Microbiota in Children with Cancer
    Gianluca Bossù, Riccardo Di Sario, Alberto Argentiero, Susanna Esposito · 2021 · Antibiotics
62. The bacteria inside human cancer cells: Mainly as cancer promoters
    Wei Zhu, Jingzi Wang, Zhixian Liu, Ji‐Fu Wei · 2022 · Frontiers in Oncology
63. The Microbiome in PDAC—Vantage Point for Future Therapies?
    Nina Pfisterer, Catharina Lingens, Cathleen Heuer, Linh Dang, Albrecht Neeße, Christoph Ammer‐Herrmenau · 2022 · Cancers
64. A Dual Drug Delivery Platform for Cancer–Bacteria Cotargeting
    Rohini Singh, Chandra Shekhar Kumar, Manidipa Banerjee, Shalini Gupta · 2019 · ACS Applied Bio Materials
65. The microbial landscape of tumors: a deep dive into intratumoral microbiota
    Sahar Asgharzadeh, Maryam Pourhajibagher, Abbas Bahador · 2025 · Frontiers in Microbiology
66. Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositis
    Ana Rita da Silva Ferreira, Hannah R. Wardill, Wim J. E. Tissing, Hermie J. M. Harmsen · 2020 · Current Opinion in Supportive and Palliative Care
67. Gut microbiota plays pivotal roles in benign and malignant hematopoiesis
    Yuxuan Li, Biao Zhang, Lingli Jiang, Tao Cheng, Hui Cheng, Pengxu Qian · 2024 · Blood Science
68. Preliminary evaluation of zeolite-based platforms as potential dual drug delivery systems against microbial infections in the tumor microenvironment
    Ana Raquel Bertão, Viktoriya Ivasiv, Cristina Almeida Aguiar, Patricia R. Correia, António Maurício C. Fonseca, Manuel Bañobre‐López, Fátima Baltazar, Isabel Correia Neves · 2023 · Microporous and Mesoporous Materials
69. The Microbiome Matters: Its Impact on Cancer Development and Therapeutic Responses
    In-Young Chung, Ji Hyun Kim, Ara Koh · 2024 · The Journal of Microbiology
70. Inflammation, microbiota, and pancreatic cancer
    Xiaoliang Chen, Feixia Sun, Xuqin Wang, Xiaoqiang Feng, Amir Reza Aref, Yu Tian, Milad Ashrafizadeh, Dengfeng Wu · 2025 · Cancer Cell International
71. The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance
    Priya Mondal, Syed Musthapa Meeran · 2023 · Cancer and Metastasis Reviews
72. The Role of the Gut Microbiome in Hematological Cancers
    Najihah Hussein, Reena Rajasuriar, Asif M. Khan, Yvonne Ai Lian Lim, Gin Gin Gan · 2023 · Molecular Cancer Research
73. An Insight into the Clinical Application of Gut Microbiota during Anticancer Therapy
    Wenyu Li, Tingtao Chen · 2022 · Advanced Gut & Microbiome Research
74. Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapy
    Massimiliano Cazzaniga, Giordano Bruno Zonzini, Francesco Di Pierro, Chiara Maria Palazzi, Marco Cardinali, Alexander Bertuccioli · 2023 · Pathology & Oncology Research
75. The Impact of Oral Antibiotics Prior to Cancer Diagnosis on Overall Patient Survival: Findings from an English Population-Based Cohort Study
    Eleni Domzaridou, Tjeerd Pieter van Staa, Andrew G. Renehan, Natalie Cook, William Welfare, Darren Mark Ashcroft, Victoria Palin · 2023 · Current Oncology
76. Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?
    Karolina Kaźmierczak-Siedlecka, Nikola Bulman, Paweł Ulasiński, Bartosz Kamil Sobocki, Karol Połom, Luigi Marano, Leszek Kalinowski, Karolina Skonieczna‐Żydecka · 2023 · Gut Microbes
77. Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?
    Jie Qiu, Yuancong Jiang, Nanwei Ye, Gan Jin, Hao Shi, Da Qian · 2024 · Journal of Translational Medicine
78. Modulation of gut microbiota in targeted cancer therapy: insights on the EGFR/VEGF/KRAS pathways
    Li Gong, Shixue Yang, Junli Huang, Yongsheng Li · 2024 · Cancer Biology and Medicine
79. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
    Manida Suksawat, Jutarop Phetcharaburanin, Poramate Klanrit, Nisana Namwat, Narong Khuntikeo, Attapon Titapun, Apiwat Jarearnrat, Vanlakhone Vilayhong, Prakasit Sa-Ngiamwibool, Anchalee Techasen et al. · 2022 · Frontiers in Public Health
80. Targeting emerging cancer hallmarks by transition metal complexes: Cancer stem cells and tumor microbiome. Part I
    Meng Rui Chang, Daniil A. Rusanov, Jemma Arakelyan, Mana M. Alshehri, A.V. Asaturova, Galina Sergeevna Kireeva, Maria V. Babak, Wee Han Ang · 2022 · Coordination Chemistry Reviews
81. Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression With Focus on Breast Cancer Therapeutic Outcomes
    Chun‐Ming Chang, Ho Yin Pekkle Lam · 2024 · Anticancer Research
82. Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study
    Hiroo Imai, Ken Saijo, Keigo Komine, Reio Ueta, Ryunosuke Numakura, Shonosuke Wakayama, Sho Umegaki, Sakura Hiraide, Yoshifumi Kawamura, Yuki Kasahara et al. · 2022 · Cancer Management and Research
83. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review)
    Xing Huang, Li Mao, Shengzhong Hou, Bole Tian · 2021 · International Journal of Oncology
84. Effects of chemotherapy and immunotherapy on microbial diversity in TME and engineered bacterial-mediated tumor therapy
    Heng Zheng, Xianxian Chen, Qiyang Li, Yuqi Liu, Jinzhong Cai · 2023 · Frontiers in Immunology
85. Targeting the gut and tumor microbiome in cancer treatment resistance
    Soňa Čierniková, Aneta Ševčíková, Michal Mego · 2024 · American Journal of Physiology-Cell Physiology
86. Microbial molecules, metabolites, and malignancy
    Ryan Michael Thomas · 2025 · Neoplasia
87. Bladder cancer microbiome and its association with chemoresponse
    Rashida Ginwala, Laura Bukavina, Mohit Sindhani, Erika J. Nachman, Suraj Peri, Jodie Franklin, Johnathan A. Drevik, Sarah S. Christianson, Daniel M. Geynisman, Alexander Kutikov et al. · 2025 · Frontiers in Oncology
88. Methotrexate Disposition, Anti-Folate Activity, and Metabolomic Profiling to Identify Molecular Markers of Disease Activity and Drug Response in the Collagen-Induced Arthritis Mouse Model
    Yezan M. Salamoun, Kishore Polireddy, Yu Kyoung Cho, Matthew R. Medcalf, Ryan Sol Funk · 2021 · Metabolites
89. Microbiome and colorectal cancer: A review of the past, present, and future
    Michael S. Johns, Nicholas James Petrelli · 2021 · Surgical Oncology
90. Prospect of bacteria for tumor diagnosis and treatment
    Yuyao Xu, Chenhao Zhao, Xin Ma, Haifang Zhang · 2022 · Life Sciences
91. Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses
    Zakia Harmak, Abdou-samad Kone, Amina Ghouzlani, Bouchra Ghazi, Abdallah Badou · 2024 · Immune Network
92. Microbial Crosstalk with Therapy: Pharmacomicrobiomics in AML—One Step Closer to Personalized Medicine
    Aneta Nowicka, Hanna Tomczak, Edyta Szałek, Agnieszka Karbownik, Lidia Gil · 2025 · Biomedicines
93. Evaluation of Bacteria and Fungi DNA Abundance in Human Tissues
    Gabriela Estrela de Albuquerque, Bruno S. Moda, Marianna Sampaio Serpa, Gabriela Pereira Branco, Alexandre Defelicibus, Isabella K. T. M. Takenaka, María Galli de Amorim, Elizabeth Cristina Miola, Valquíria do Carmo Alves Martins, Kátia Luz Torres et al. · 2022 · Genes
94. A new perspective in the prevention and treatment of antitumor therapy-related cardiotoxicity: Intestinal microecology
    Chenchen Meng, Xiaoming Wang, Lu Fan, Yajie Fan, Zhipeng Yan, Yunjiao Wang, Yanyang Li, Junping Zhang, Shichao Lv · 2023 · Biomedicine & Pharmacotherapy
95. Nanomedicines via the pulmonary route: a promising strategy to reach the target?
    Mélina Guérin, Élise Lepeltier · 2024 · Drug Delivery and Translational Research
96. Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells
    Szandra Schwarcz, Petra Nyerges, Tímea Ingrid Bíró, Eszter Anna Janka, Péter Bai, Edit Mikó · 2024 · Molecules
97. Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?
    María Bucci-Muñoz, Aldana Magalí Gola, Juan Pablo Rigalli, María Paula Ceballos, María Laura Ruiz · 2023 · Life
98. Drug Response Diversity: A Hidden Bacterium?
    Nadji Hannachi, Laurence Camoin‐Jau · 2021 · Journal of Personalized Medicine
99. ML218 HCl Is More Efficient Than Capsaicin in Inhibiting Bacterial Antigen-Induced Cal 27 Oral Cancer Cell Proliferation
    Rajdeep Chakraborty, Honghua Hu, Charbel Darido, Karen Vickery, Shoba Ranganathan · 2021 · International Journal of Molecular Sciences
100. The Anti- and Pro-Tumorigenic Role of Microbiota and Its Role in Anticancer Therapeutic Strategies
     Giulia Greco, Sabrina Donati Zeppa, Deborah Agostini, Giuseppe Attisani, Claudio Stefanelli, Fabio Ferrini, Piero Sestili, Carmela Fimognari · 2022 · Cancers